Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 25
Filtrar
Mais filtros

Medicinas Complementares
Tipo de documento
Intervalo de ano de publicação
1.
J Transl Med ; 21(1): 719, 2023 10 13.
Artigo em Inglês | MEDLINE | ID: mdl-37833712

RESUMO

BACKGROUND: Polyploid giant cancer cells (PGCCs), a specific type of cancer stem cells (CSCs), can be induced by hypoxic microenvironments, chemical reagents, radiotherapy, and Chinese herbal medicine. Moreover, PGCCs can produce daughter cells that undergo epithelial-mesenchymal transition, which leads to cancer recurrence and disseminated metastasis. Vimentin, a mesenchymal cell marker, is highly expressed in PGCCs and their daughter cells (PDCs) and drives migratory persistence. This study explored the molecular mechanisms by which vimentin synergistically regulates PGCCs to generate daughter cells with enhanced invasive and metastatic properties. METHODS: Arsenic trioxide (ATO) was used to induce the formation of PGCCs in Hct116 and LoVo cells. Immunocytochemical and immunohistochemical assays were performed to determine the subcellular localization of vimentin. Cell function assays were performed to compare the invasive metastatic abilities of the PDCs and control cells. The molecular mechanisms underlying vimentin expression and nuclear translocation were investigated by real-time polymerase chain reaction, western blotting, cell function assays, cell transfection, co-immunoprecipitation, and chromatin immunoprecipitation, followed by sequencing. Finally, animal xenograft experiments and clinical colorectal cancer samples were used to study vimentin expression in tumor tissues. RESULTS: Daughter cells derived from PGCCs showed strong proliferative, migratory, and invasive abilities, in which vimentin was highly expressed and located in both the cytoplasm and nucleus. Vimentin undergoes small ubiquitin-like modification (SUMOylation) by interacting with SUMO1 and SUMO2/3, which are associated with nuclear translocation. P62 regulates nuclear translocation of vimentin by controlling SUMO1 and SUMO2/3 expression. In the nucleus, vimentin acts as a transcription factor that regulates CDC42, cathepsin B, and cathepsin D to promote PDC invasion and migration. Furthermore, animal experiments and human colorectal cancer specimens have confirmed the nuclear translocation of vimentin. CONCLUSION: P62-dependent SUMOylation of vimentin plays an important role in PDC migration and invasion. Vimentin nuclear translocation and overexpressed P62 of cancer cells may be used to predict patient prognosis, and targeting vimentin nuclear translocation may be a promising therapeutic strategy for metastatic cancers.


Assuntos
Neoplasias Colorretais , Células Gigantes , Animais , Humanos , Vimentina/metabolismo , Linhagem Celular Tumoral , Células Gigantes/metabolismo , Células Gigantes/patologia , Transição Epitelial-Mesenquimal , Neoplasias Colorretais/patologia , Poliploidia , Movimento Celular , Microambiente Tumoral
2.
BMJ Case Rep ; 15(6)2022 Jun 06.
Artigo em Inglês | MEDLINE | ID: mdl-35667693

RESUMO

Giant cell myositis (GCM) is a rare inflammatory myopathy associated with myasthenia gravis and thymoma. Here, we report on a woman in her late 50s with a history of myasthenia gravis, systemic lupus erythematosus and stage IV thymoma with pleural metastases, who presented with proximal weakness, neuromuscular respiratory failure and hypercalcaemia. She was diagnosed with GCM via muscle biopsy and screened for myocarditis but showed no evidence of myocardial involvement. Her hypercalcaemia was consistent with a granulomatous process, likely driven by her GCM. Her strength gradually improved, and her hypercalcaemia did not recur after treatment with high dose steroids, intravenous immune globulin and plasma exchange. Her course was complicated by several opportunistic infections in the setting of her immunosuppression. Despite the high morbidity associated with GCM, she demonstrated clinical improvement after initiating immunosuppressive therapy and continues to be managed in the outpatient setting.


Assuntos
Hipercalcemia , Miastenia Gravis , Miosite , Timoma , Neoplasias do Timo , Feminino , Células Gigantes/patologia , Humanos , Hipercalcemia/complicações , Miastenia Gravis/complicações , Miosite/diagnóstico , Recidiva Local de Neoplasia/patologia , Timoma/complicações , Timoma/patologia , Neoplasias do Timo/complicações , Neoplasias do Timo/patologia
3.
Sci Rep ; 11(1): 12144, 2021 06 09.
Artigo em Inglês | MEDLINE | ID: mdl-34108508

RESUMO

In bone regeneration induced by the combination of mesenchymal stromal cells (MSCs) and calcium-phosphate (CaP) materials, osteoclasts emerge as a pivotal cell linking inflammation and bone formation. Favorable outcomes are observed despite short-term engraftments of implanted MSCs, highlighting their major paracrine function and the possible implication of cell death in modulating their secretions. In this work, we focused on the communication from MSCs towards osteoclasts-like cells in vitro. MSCs seeded on a CaP biomaterial or undergoing induced apoptosis produced a conditioned media favoring the development of osteoclasts from human CD14+ monocytes. On the contrary, MSCs' apoptotic secretion inhibited the development of inflammatory multinucleated giant cells formed after IL-4 stimulation. Components of MSCs' secretome before and after apoptotic stress were compared using mass spectrometry-based quantitative proteomics and a complementary immunoassay for major cytokines. CXCR-1 and CXCR-2 ligands, primarily IL-8/CXCL-8 but also the growth-regulated proteins CXCL-1, -2 or -3, were suggested as the major players of MSCs' pro-osteoclastic effect. These findings support the hypothesis that osteoclasts are key players in bone regeneration and suggest that apoptosis plays an important role in MSCs' effectiveness.


Assuntos
Apoptose , Células da Medula Óssea/citologia , Diferenciação Celular , Células Gigantes/patologia , Células-Tronco Mesenquimais/citologia , Osteoclastos/citologia , Osteogênese , Células da Medula Óssea/fisiologia , Proliferação de Células , Citocinas , Células Gigantes/metabolismo , Humanos , Células-Tronco Mesenquimais/fisiologia , Osteoclastos/fisiologia
4.
Am J Surg Pathol ; 42(10): 1286-1296, 2018 10.
Artigo em Inglês | MEDLINE | ID: mdl-29944471

RESUMO

Prostatic adenocarcinoma with focal pleomorphic giant cell features is rare with the only prior series consisting of 6 cases. From 2005 to 2018, we identified 29 cases from our consult service and 1 case from our own institution. Men ranged in age from 39 to 90 years (median=75.5). Diagnostic specimens consisted of needle biopsies (n=13); transurethral resections (n=7), urethral/bladder biopsies (n=8), radical prostatectomy (n=1), and orchiectomy (n=1). In all cases, there was usual acinar prostatic adenocarcinoma, where the highest grade in all cases was Gleason score 9 to 10 (Grade Group 5). On average, 68% of the involved cores had cancer with a maximum percent of cancer averaging 55%; on average, transurethral resections had 85% of the area involved by cancer. Areas of cancer showing pleomorphic giant cell features were focal (<5%). Two of the needle biopsies showed extraprostatic extension. The radical prostatectomy had seminal vesicle invasion and positive margins with lymphovascular invasion. Prostatic adenocarcinoma with focal pleomorphic giant cell features is always accompanied by extensive usual acinar prostate adenocarcinoma where the highest grade in all cases was Gleason score 9 to 10 (Grade Group 5). Although the pleomorphic component is focal, it can mimic urothelial carcinoma. IHC can be misleading as PSA staining is often negative or focal in both the pleomorphic and usual prostatic adenocarcinoma components. NKX3.1 is the most sensitive prostate marker, but was still focal in 1 usual prostatic adenocarcinoma and negative in 2 pleomorphic components. Prostatic adenocarcinoma with focal pleomorphic giant cell features has a dismal prognosis. In men with no prior diagnosis of prostate adenocarcinoma and >1-year follow-up, 7/19 (37%) were dead at a median of 8 months after diagnosis. Of the 7 men with a prior history of prostate adenocarcinoma, 4/7 (57%) were dead at a median of 7 months after diagnosis of recurrent prostate adenocarcinoma with pleomorphic giant cell features.


Assuntos
Adenocarcinoma/patologia , Carcinoma de Células Gigantes/patologia , Células Gigantes/patologia , Neoplasias da Próstata/patologia , Adenocarcinoma/química , Adenocarcinoma/mortalidade , Adenocarcinoma/cirurgia , Adulto , Idoso , Idoso de 80 Anos ou mais , Biópsia por Agulha , Carcinoma de Células Gigantes/química , Carcinoma de Células Gigantes/mortalidade , Carcinoma de Células Gigantes/cirurgia , Células Gigantes/química , Proteínas de Homeodomínio/análise , Humanos , Imuno-Histoquímica , Calicreínas/análise , Masculino , Pessoa de Meia-Idade , Gradação de Tumores , Orquiectomia , Antígeno Prostático Específico/análise , Neoplasias da Próstata/química , Neoplasias da Próstata/mortalidade , Neoplasias da Próstata/cirurgia , Fatores de Risco , Fatores de Transcrição/análise , Ressecção Transuretral da Próstata , Resultado do Tratamento
5.
Brain Tumor Pathol ; 33(1): 57-62, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-26602910

RESUMO

Epithelioid glioblastomas (E-GBMs) are rare, highly aggressive tumors consisting of closely packed tumor cells with smooth, round cell borders and abundant eosinophilic cytoplasm. They tend to affect younger patients compared with conventional GBM. BRAF V600E mutation is characteristically found in approximately 50% of all E-GBMs, compared with a low frequency of this mutation in conventional GBM. Here, we report an unusual case of glioma involving the right frontal lobe, basal ganglia and thalamus in an HIV-positive 30-year-old man on antiretroviral therapy. The lesion was composed of abundant discohesive, monotonous epithelioid cells with extensive necrosis, spindle and polyhedral cells, low-grade oligoastrocytoma-like areas, sarcomatous components, and numerous osteoclast-like giant cells (OLGCs) intermingled with epithelioid tumor cells. As the epithelioid cells accounted for more than one-third of the tumor, a pathological diagnosis of E-GBM was made. BRAF V600E mutation was detected in both oligoastrocytoma-like and epithelioid cell components. Similar to previously reported findings on E-GBM associated with low-grade glioma, this case suggested that low-grade astrocytic glioma with BRAF V600E mutation progressed to E-GBM. OLGCs are rarely observed in gliomas, and this is the first case report of E-GBM associated with abundant OLGC infiltration.


Assuntos
Neoplasias Encefálicas/genética , Neoplasias Encefálicas/patologia , Glioblastoma/genética , Glioblastoma/patologia , Mutação , Proteínas Proto-Oncogênicas B-raf/genética , Adulto , Astrocitoma/diagnóstico , Astrocitoma/genética , Astrocitoma/patologia , Gânglios da Base/patologia , Neoplasias Encefálicas/diagnóstico , Transformação Celular Neoplásica , Progressão da Doença , Lobo Frontal/patologia , Células Gigantes/patologia , Glioblastoma/diagnóstico , Soropositividade para HIV , Humanos , Masculino , Osteoclastos/patologia , Tálamo/patologia
6.
PLoS One ; 10(11): e0140721, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26536025

RESUMO

In order to further understand the role of tumor heterogeneity in metastasis and chemo-resistance, high metastatic PC-3 human prostate cancer variants were selected by injecting parental PC-3 cells, expressing green fluorescent protein (GFP) in the footpad of nude mice, which then metastasize to inguinal lymph nodes. The PC-3-GFP cells which metastasized to the inguinal lymph nodes were collected and were re-injected to the footpad. After 6 such cycles, the PC-3-GFP cells collected from inguinal lymph nodes (PC-3-GFP-LN) were again injected to the footpad. PC-3-GFP-LN showed 100% metastasis to major lymph nodes (popliteal, inguinal, axillary, and cervical), and 100% metastasis to bone and lung. The percent of giant cell variants was enriched in PC-3-GFP-LN-6 compared to parental cells and increased with each cycle of selection, which in turn had increased metastasis. PC-3-GFP-LN-6 cells were resistant to 5-fluorouracil, doxorubicin and cisplatinum, compared to parental PC-3. However, PC-3-GFP-LN-6 was sensitive to the traditional Chinese medicine (TCM) herbal mixture LQ, similar to the parental cells. These results suggest that PC-3 tumors are heterogenous and that subpopulations of highly metastatic, drug-resistant cells can be step-wise selected using a mouse model of tumor progression.


Assuntos
Resistencia a Medicamentos Antineoplásicos , Células Gigantes/patologia , Neoplasias da Próstata/patologia , Animais , Antineoplásicos/uso terapêutico , Antineoplásicos/toxicidade , Neoplasias Ósseas/patologia , Neoplasias Ósseas/secundário , Linhagem Celular Tumoral , Sobrevivência Celular , Cisplatino/uso terapêutico , Cisplatino/toxicidade , Doxorrubicina/uso terapêutico , Doxorrubicina/toxicidade , Resistencia a Medicamentos Antineoplásicos/genética , Medicamentos de Ervas Chinesas/uso terapêutico , Medicamentos de Ervas Chinesas/toxicidade , Fluoruracila/uso terapêutico , Fluoruracila/toxicidade , Genes Reporter , Células Gigantes/citologia , Proteínas de Fluorescência Verde/genética , Proteínas de Fluorescência Verde/metabolismo , Humanos , Neoplasias Pulmonares/patologia , Neoplasias Pulmonares/secundário , Linfonodos/patologia , Metástase Linfática , Masculino , Medicina Tradicional Chinesa , Camundongos , Camundongos Nus , Neoplasias da Próstata/tratamento farmacológico , Neoplasias da Próstata/metabolismo , Transplante Heterólogo
7.
J Periodontol ; 86(6): 801-11, 2015 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-25741581

RESUMO

BACKGROUND: Acupuncture has shown the capability of modulating the immuno-inflammatory response of the host. This study aims to evaluate the effects of electroacupuncture (EA) on ligature-induced periodontitis in rats. METHODS: Thirty-two animals were divided into four groups: 1) control; 2) experimental periodontitis (EP); 3) sham-treated (EP/EA-sham); and 4) treated with EA (EP/EA). For the EP groups, a ligature was placed around the right mandibular first molars at day 1. Sessions of EA or EA-sham were assigned every other day. For EA treatment, large intestine meridian points LI4 and LI11 and stomach meridian points ST36 and ST44 were used. EA-sham was performed in off-meridian points. Animals were euthanized at day 11. Histomorphometric and microtomographic analyses were performed. Immunolabeling patterns for the receptor activator of nuclear factor κB ligand (RANKL), osteoprotegerin (OPG), and tartrate-resistant acid phosphatase (TRAP) were assessed. Expressions of interleukin (IL)-1ß, matrix metalloproteinase (MMP)-8, IL-6, and cyclooxygenase (COX)-2 messenger RNAs (mRNAs) were evaluated by quantitative reverse transcription-polymerase chain reaction. Data were analyzed statistically (P <0.05, analysis of variance). RESULTS: Histomorphometric and microtomographic analyses demonstrated that group EP/EA presented reduced alveolar bone loss when compared to group EP (P <0.05). Reduced RANKL immunolabeling and fewer TRAP-positive multinucleated cells were observed in the EA-treated group in relation to group EP. No differences were observed in OPG expression among groups. EA treatment decreased the genic expression of IL-1ß and MMP-8 (P <0.05), increased the mRNA expression of IL-6 (P <0.05), and did not modify the genic expression of COX-2 in animals with EP (P >0.05). CONCLUSION: It can be concluded that EA reduced periodontal tissue breakdown and the expression of some proinflammatory mediators and a proresorptive factor in EP in rats.


Assuntos
Eletroacupuntura/métodos , Periodontite/terapia , Fosfatase Ácida/análise , Pontos de Acupuntura , Perda do Osso Alveolar/patologia , Perda do Osso Alveolar/terapia , Animais , Densidade Óssea/fisiologia , Ciclo-Oxigenase 2/análise , Células Gigantes/patologia , Processamento de Imagem Assistida por Computador/métodos , Interleucina-1beta/análise , Interleucina-6/análise , Isoenzimas/análise , Masculino , Metaloproteinase 8 da Matriz/análise , Osteoprotegerina/análise , Ligamento Periodontal/química , Ligamento Periodontal/patologia , Periodontite/metabolismo , Periodontite/patologia , Ratos , Ratos Wistar , Receptor Ativador de Fator Nuclear kappa-B/análise , Fosfatase Ácida Resistente a Tartarato , Microtomografia por Raio-X/métodos
8.
J Clin Periodontol ; 42(1): 81-8, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25370371

RESUMO

AIM: The objective of study was to determine the osteogenic potential of bone morphogenetic protein-2 (BMP-2) loaded onto a particulate porcine bone mineral (PBM) biomaterial using a sinus augmentation model. METHODS: Release kinetics of BMP-2/PBM was determined in vitro. Eight rabbits received BMP-2/PBM or PBM alone into contra-lateral sinus sites. The animals were killed following a 2-week healing interval for micro-CT and histometrical analysis. RESULTS: Approximately 40% of the BMP-2 was released from PBM over the first 3 days in vitro; release maintained at a reduced level through day 21. In vivo, total augmented implant volume did not differ significantly between treatments. However, local bone formation was enhanced in the BMP-2/PBM group compared with PBM control (10.5% versus 6.6%; p = 0.03), specifically in the central aspect of the PBM implant (14.2% versus 5.5%; p < 0.01) and adjoining the Schneiderian membrane (11.9% versus 5.0%; p < 0.05). There were no significant overall differences in residual biomaterial and fibrovascular tissue. CONCLUSION: Bone morphogenetic protein-2 enhanced local bone formation in the rabbit maxillary sinus model following implantation using a PBM carrier.


Assuntos
Materiais Biocompatíveis/uso terapêutico , Proteína Morfogenética Óssea 2/uso terapêutico , Substitutos Ósseos/uso terapêutico , Osteogênese/efeitos dos fármacos , Levantamento do Assoalho do Seio Maxilar/métodos , Animais , Proteína Morfogenética Óssea 2/farmacocinética , Avaliação Pré-Clínica de Medicamentos , Células Gigantes/patologia , Processamento de Imagem Assistida por Computador/métodos , Imageamento Tridimensional/métodos , Masculino , Seio Maxilar/efeitos dos fármacos , Seio Maxilar/patologia , Mucosa Nasal/efeitos dos fármacos , Mucosa Nasal/patologia , Coelhos , Distribuição Aleatória , Suínos , Microtomografia por Raio-X/métodos
9.
BMB Rep ; 45(5): 281-6, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22617451

RESUMO

Osteoclasts are multinucleated cells that are formed by the fusion of pre-fusion osteoclasts (pOCs). The fusion of pOCs is known to be important for osteoclastic bone resorption. Here, we examined the effect of IFN-γ on the fusion of pOCs. IFN-γ greatly increased the fusion of pOCs in a dose-dependent manner. Furthermore, IFN-γ induced pOC fusion even in hydroxyapatite-coated plates used as a substitute for bone. The resorption area of pOCs stimulated with IFN-γ was significantly higher than that of the control cells. IFN-γ induced the expression of dendritic cell-specific transmembrane protein (DC-STAMP), which is responsible for the fusion of pOCs. IFN-γ enhanced DC-STAMP expression in a dose-dependent manner. The mRNA expression of c-Fos and nuclear factor of activated T cells (NFAT) c1 was enhanced in the pOCs treated with IFN-γ. Taken together, these results provide a new insight into the novel role of IFN-γ on the fusion of pOCs.


Assuntos
Reabsorção Óssea/patologia , Células Gigantes/efeitos dos fármacos , Células Gigantes/patologia , Interferon gama/farmacologia , Osteoclastos/efeitos dos fármacos , Animais , Diferenciação Celular/efeitos dos fármacos , Diferenciação Celular/fisiologia , Fusão Celular , Núcleo Celular/efeitos dos fármacos , Núcleo Celular/patologia , Núcleo Celular/fisiologia , Células Cultivadas , Citocinas/genética , Citocinas/metabolismo , Avaliação Pré-Clínica de Medicamentos , Expressão Gênica/efeitos dos fármacos , Células Gigantes/fisiologia , Interferon gama/fisiologia , Masculino , Camundongos , Camundongos Endogâmicos ICR , Osteoclastos/patologia , Osteoclastos/fisiologia , Regulação para Cima/efeitos dos fármacos
10.
J Appl Oral Sci ; 18(3): 273-8, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20857007

RESUMO

UNLABELLED: Castor oil bean cement (COB) is a new material that has been used as an endodontic sealer, and is a candidate material for direct pulp capping. OBJECTIVE: The purpose of this study was to evaluate the biocompatibility of a new formulation of COB compared to calcium hydroxide cement (CH) and a control group without any material, in the subcutaneous tissue of rats. MATERIAL AND METHODS: The materials were prepared, packed into polyethylene tubes, and implanted in the rat dorsal subcutaneous tissue. Animals were sacrificed at the 7th and 50th days after implantation. A quantitative analysis of inflammatory cells was performed and data were subjected to ANOVA and Tukey's tests at 5% significance level. RESULTS: Comparing the mean number of inflammatory cells between the two experimental groups (COB and CH) and the control group, statistically significant difference (p=0.0001) was observed at 7 and 50 days. There were no significant differences (p=0.111) between tissue reaction to CH (382 inflammatory cells) and COB (330 inflammatory cells) after 7 days. After 50 days, significantly more inflammatory cells (p=0.02) were observed in the CH group (404 inflammatory cells) than in the COB group (177 inflammatory cells). CONCLUSIONS: These results demonstrate that the COB cement induces less inflammatory response within long periods.


Assuntos
Materiais Biocompatíveis/farmacologia , Hidróxido de Cálcio/farmacologia , Óleo de Rícino/farmacologia , Agentes de Capeamento da Polpa Dentária e Pulpectomia/farmacologia , Tela Subcutânea/efeitos dos fármacos , Animais , Contagem de Células , Tecido Conjuntivo/patologia , Eosinófilos/patologia , Células Gigantes/patologia , Inflamação/patologia , Linfócitos/patologia , Macrófagos/patologia , Masculino , Minerais/farmacologia , Neovascularização Fisiológica/efeitos dos fármacos , Neutrófilos/patologia , Plasmócitos/patologia , Ratos , Ratos Wistar , Resinas Vegetais/farmacologia , Método Simples-Cego , Tela Subcutânea/patologia , Fatores de Tempo
11.
Autoimmun Rev ; 9(11): 780-4, 2010 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-20620241

RESUMO

Diffuse-type tenosynovial giant cell tumors, also known as pigmented villonodular synovitis, are unique mesenchymal lesions that arise from the synovial tissue of the joints. They are predominantly intraarticular, aggressive, infiltrative processes, characterized by both inflammatory or neoplastic properties and local destructive progression. The pattern of synovial gene and protein expressions in pigmented villonodular synovitis, similar to those in activated macrophages in rheumatoid arthritis, and the phenotype of multinucleated giant cells, characteristic of osteoclasts, suggest that there is a common autocrine mechanism in osteoclast differentiation in both diseases and indicate the potential utility of tumor necrosis factor (TNF)-alpha blockade. High synovial colony stimulating factor 1 (CSF1) messenger RNA (m RNA) expression in pigmented villonodular synovitis, unrelated to a chromosomal translocation involving CSF1 locus, may indicate that there is a synergic paracrine loop mediated by TNF-alpha and CSF1, as shown in both inflammatory and neoplastic conditions. The effects of a new therapeutic approach consisting in intraarticular TNF-alpha blockade were studied in four pigmented villonodular synovitis knees. Knee injections produced a rapid reduction in clinical and sonographic indexes and immunohistological alterations, confirmed by arthroscopic synovectomy. A delayed relapse in one of the four knees and unaltered synovial CSF1 expression were other important findings. In the light of these observations, CSF1/CSF1R interaction probably represents a more sensible therapeutic target than TNF-alpha blockade in the diffuse form of pigmented villonodular synovitis.


Assuntos
Articulação do Joelho , Fator Estimulador de Colônias de Macrófagos/metabolismo , Membrana Sinovial/imunologia , Membrana Sinovial/patologia , Sinovite Pigmentada Vilonodular/imunologia , Sinovite Pigmentada Vilonodular/metabolismo , Fator de Necrose Tumoral alfa/antagonistas & inibidores , Adulto , Artrite/tratamento farmacológico , Artrite/imunologia , Artrite/metabolismo , Artrite/patologia , Células do Tecido Conjuntivo , Feminino , Expressão Gênica , Tumores de Células Gigantes/imunologia , Tumores de Células Gigantes/patologia , Células Gigantes/metabolismo , Células Gigantes/patologia , Humanos , Articulação do Joelho/patologia , Fator Estimulador de Colônias de Macrófagos/biossíntese , Fator Estimulador de Colônias de Macrófagos/genética , Masculino , Pessoa de Meia-Idade , RNA Mensageiro/biossíntese , RNA Mensageiro/genética , Transdução de Sinais , Líquido Sinovial/metabolismo , Sinovite Pigmentada Vilonodular/tratamento farmacológico , Sinovite Pigmentada Vilonodular/patologia
12.
J. appl. oral sci ; 18(3): 273-278, May-June 2010. ilus
Artigo em Inglês | LILACS | ID: lil-557093

RESUMO

Castor oil bean cement (COB) is a new material that has been used as an endodontic sealer, and is a candidate material for direct pulp capping. OBJECTIVE: The purpose of this study was to evaluate the biocompatibility of a new formulation of COB compared to calcium hydroxide cement (CH) and a control group without any material, in the subcutaneous tissue of rats. MATERIAL AND METHODS: The materials were prepared, packed into polyethylene tubes, and implanted in the rat dorsal subcutaneous tissue. Animals were sacrificed at the 7th and 50th days after implantation. A quantitative analysis of inflammatory cells was performed and data were subjected to ANOVA and Tukey's tests at 5 percent significance level. RESULTS: Comparing the mean number of inflammatory cells between the two experimental groups (COB and CH) and the control group, statistically significant difference (p=0.0001) was observed at 7 and 50 days. There were no significant differences (p=0.111) between tissue reaction to CH (382 inflammatory cells) and COB (330 inflammatory cells) after 7 days. After 50 days, significantly more inflammatory cells (p=0.02) were observed in the CH group (404 inflammatory cells) than in the COB group (177 inflammatory cells). CONCLUSIONS: These results demonstrate that the COB cement induces less inflammatory response within long periods.


Assuntos
Animais , Masculino , Ratos , Materiais Biocompatíveis/farmacologia , Hidróxido de Cálcio/farmacologia , Óleo de Rícino/farmacologia , Agentes de Capeamento da Polpa Dentária e Pulpectomia/farmacologia , Tela Subcutânea/efeitos dos fármacos , Contagem de Células , Tecido Conjuntivo/patologia , Eosinófilos/patologia , Células Gigantes/patologia , Inflamação/patologia , Linfócitos/patologia , Macrófagos/patologia , Minerais/farmacologia , Neovascularização Fisiológica/efeitos dos fármacos , Neutrófilos/patologia , Plasmócitos/patologia , Ratos Wistar , Resinas Vegetais/farmacologia , Método Simples-Cego , Tela Subcutânea/patologia , Fatores de Tempo
13.
Dent Mater ; 25(7): 863-7, 2009 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-19203785

RESUMO

OBJECTIVE: To evaluate the biocompatibility of resin composite specimens with different curing efficiency, subcutaneously implanted in rats with experimentally induced arthritis. METHODS: The amount of remaining CC bonds (%RDB) of hybrid resin composite specimens photopolymerized for 10s and 40s exposure time (n=3) was measured by micro-attenuated total reflectance Fourier transform infrared spectroscopy. Male Wistar rats (n=36) were classified in two groups (n=18) of healthy animals and of animals with experimentally induced arthritis. Resin composite specimens irradiated for 10s and 40s and calcium hydroxide control specimens were implanted subcutaneously in each animals' dorsum. Following 2-, 4- and 9-week periods the animals were sacrificed. The development of arthritis was defined by biochemical analysis and the changes in the relative weight of animals' organs (spleen, thymus, adrenals). Tissue reactions were examined histologically. RESULTS: %RDB per site and exposure time showed statistically significant differences. Lowest %RDB values were recorded on 40s exposed specimens. Biochemical indices and relative organ weights demonstrated statistically significant differences between healthy animals and animals with arthritis. The health status of the animals and the materials used did not influence tissue response. First and second periods of sacrifice showed reduced propensity of connective tissue development in comparison to the third period. The same applied for the second period regarding the presence of giant cells. SIGNIFICANCE: The materials tested and the animals' health status did not result in altered tissue response compared to control group. The period of sacrifice was associated with different tissue responses.


Assuntos
Artrite Experimental/fisiopatologia , Materiais Biocompatíveis/farmacologia , Resinas Compostas/farmacologia , Materiais Dentários/farmacologia , Tela Subcutânea/efeitos dos fármacos , Glândulas Suprarrenais/efeitos dos fármacos , Glândulas Suprarrenais/patologia , Animais , Artrite Experimental/patologia , Materiais Biocompatíveis/química , Hidróxido de Cálcio/química , Hidróxido de Cálcio/farmacologia , Carbono/química , Resinas Compostas/química , Tecido Conjuntivo/efeitos dos fármacos , Tecido Conjuntivo/patologia , Materiais Dentários/química , Células Gigantes/efeitos dos fármacos , Células Gigantes/patologia , Masculino , Teste de Materiais , Tamanho do Órgão , Processos Fotoquímicos , Distribuição Aleatória , Ratos , Ratos Wistar , Espectroscopia de Infravermelho com Transformada de Fourier , Baço/efeitos dos fármacos , Baço/patologia , Tela Subcutânea/patologia , Timo/efeitos dos fármacos , Timo/patologia , Fatores de Tempo
14.
Mod Rheumatol ; 16(6): 343-9, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-17164994

RESUMO

Patients with rheumatoid arthritis commonly suffer both systemic and periarticular osteoporosis. Bisphosphonates (BPs) are inhibitors of bone resorption, and several derivatives have been developed for treatment of enhanced bone resorption. We aimed to characterize osteoclast formation in two different sites, the proximal tibial and distal tibial areas, in rats with adjuvant arthritis, and to investigate the impact of amino or non-amino types of bisphosphonate. Adjuvant arthritis was initiated in rats while administering daily injections of either etidronate, a non-amino BP, or alendronate, an amino BP, for 3 weeks. On the day following the last injection, bone mineral density (BMD) was measured in the proximal tibia to assess systemic osteoporosis and in the distal tibia for periarticular osteoporosis using dual-energy X-ray absorptiometry. Subsequently, bone marrow cells from either end of the tibia were collected and incubated for 7 days before staining and counting tartrate-resistant acid phosphatase positive cells. In the rats with adjuvant arthritis, BMD of either end of the tibia was lower than in normal rats. Although etidronate prevented bone mineral loss at both ends, distal loss was significantly less than proximal. In contrast, alendronate significantly inhibited mineral loss primarily in the proximal area. Large osteoclasts, defined as having five or more nuclei, formed preferentially in the proximal tibia, while small osteoclasts with fewer than four nuclei were found mainly distally. The suppressive effect of alendronate was greater on the large osteoclasts, while etidronate had a greater effect on the small osteoclasts. These results show that the size and multinuclearity of osteoclasts and the number of osteoclasts formed are different in the distal and proximal areas of the tibia, and that alendronate and etidronate may suppress different types of osteoclasts as discriminated by the number of nuclei.


Assuntos
Alendronato/farmacologia , Conservadores da Densidade Óssea/farmacologia , Ácido Etidrônico/farmacologia , Osteoclastos/patologia , Osteoporose/patologia , Absorciometria de Fóton , Fosfatase Ácida/metabolismo , Animais , Artrite Experimental/complicações , Artrite Experimental/tratamento farmacológico , Artrite Experimental/patologia , Densidade Óssea/efeitos dos fármacos , Células da Medula Óssea/efeitos dos fármacos , Células da Medula Óssea/metabolismo , Células da Medula Óssea/patologia , Células Cultivadas , Relação Dose-Resposta a Droga , Células Gigantes/efeitos dos fármacos , Células Gigantes/patologia , Isoenzimas/metabolismo , Masculino , Osteoclastos/efeitos dos fármacos , Osteoporose/tratamento farmacológico , Osteoporose/etiologia , Ratos , Ratos Endogâmicos Lew , Fosfatase Ácida Resistente a Tartarato , Tíbia/efeitos dos fármacos , Tíbia/metabolismo , Tíbia/patologia
15.
J Craniofac Surg ; 17(3): 420-5, 2006 May.
Artigo em Inglês | MEDLINE | ID: mdl-16770175

RESUMO

Traditional formulations of bone wax are composed largely of beeswax and are well known to interfere with bone healing and cause inflammatory reactions. Ostene, a newly available bone hemostasis agent made of water-soluble alkylene oxide copolymers, was evaluated. The soft tissue response to Ostene was compared with bone wax and a polyethylene control after implantation into the paravertebral muscles of three rabbits. After 2 weeks, Ostene elicited no fibrous response, the polyethylene elicited a thin (less than 0.5 mm) fibrous response, and the bone wax was encased in a fibrous capsule 0.6 to 1.0 mm thick infiltrated with inflammatory cells. The effects of Ostene were compared with bone wax in a femur defect model in eight rabbits. Ostene showed no evidence of an adverse response in the cortical defect site, medullary cavity, or the surrounding tissue at 4 and 8 weeks. In contrast, bone wax at both time intervals elicited a foreign body response consisting of fibrous tissue infiltrated by macrophages, giant cells, and lymphocytes at the sites of the bone defects. Bone wax also displaced the bone marrow and interfered with bone ingrowth into the defects. Ostene provides the clinician a water-soluble bone hemostasis material that does not demonstrate the adverse tissue response or the interference with bone healing seen with the use of bone wax.


Assuntos
Hemostáticos/uso terapêutico , Poloxâmero/uso terapêutico , Animais , Tecido Conjuntivo/patologia , Combinação de Medicamentos , Feminino , Fêmur/patologia , Fêmur/cirurgia , Reação a Corpo Estranho/etiologia , Células Gigantes/patologia , Hemostáticos/química , Linfócitos/patologia , Macrófagos/patologia , Músculo Esquelético/patologia , Músculo Esquelético/cirurgia , Osteogênese/fisiologia , Palmitatos/uso terapêutico , Poloxâmero/química , Polietileno/uso terapêutico , Polímeros/química , Polímeros/uso terapêutico , Coelhos , Solubilidade , Fatores de Tempo , Água , Ceras/uso terapêutico , Cicatrização/fisiologia
16.
J Clin Forensic Med ; 11(4): 208-10, 2004 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-15363755

RESUMO

We report the case of a 41-year-old patient with bilateral hemorrhage of the thalamus, leading to death. Post-mortem examination showed acute myocarditis. Neuropathological study showed perivascular infiltrates in affected thalamic regions. Laboratory investigation failed to find any causal agent. We hypothesize an infective agent, affecting the heart and thalamus, as the cause of this syndrome. Diaschisis due to the strategic anatomical position of the thalamus may have been responsible for coma state and death.


Assuntos
Hemorragia/patologia , Miocardite/patologia , Doenças Talâmicas/patologia , Tálamo/patologia , Adulto , Evolução Fatal , Células Gigantes/patologia , Humanos , Macrófagos/patologia , Masculino , Miocárdio/patologia , Miócitos Cardíacos/patologia , Necrose , Linfócitos T/patologia
17.
Int Endod J ; 35(9): 775-83, 2002 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12449029

RESUMO

AIM: The purpose of this study was to evaluate healing responses following repair of furcation perforations, with and without an internal matrix. Two matrix materials, HAPSET (65% non-resorbable hydroxyapatite and 35% plaster of paris) and hydroxyapatite were compared. METHODOLOGY: Four adult female baboons (Papio anubis) served as experimental models. Furcation perforations were made in the molar and premolar teeth, which were then randomly assigned to one of the five groups, according to the method of perforation repair: 1 Experimental group 1 (16 teeth): The matrix material was HAPSET and the sealing material, amalgam. 2 Experimental group 2 (16 teeth): The matrix material was hydroxyapatite and the sealing material, amalgam. 3 Experimental group 3 (16 teeth): No matrix was placed. The sealing material was amalgam. 4 Positive control group (16 teeth): The perforation was not sealed. 5 Negative control group (16 teeth): No perforation was made. The animals were sacrificed at 1 week and 1, 3 and 7 months. Specimens were prepared for examination with light microscopy. RESULTS: The data revealed that when amalgam was used alone without a matrix, there was marked extrusion of the material into the underlying bone with an associated severe inflammatory response, which continued throughout the observational period. When an internal matrix was used, there was an initial acute inflammatory response that diminished with time such that at 7 months, 75% of these specimens were free of inflammation. There was no difference in the tissue response to the different matrix materials. HAPSET and hydroxyapatite underwent connective tissue encapsulation in the early stages followed by new bone deposition in direct contact with the materials. CONCLUSIONS: Within this animal model healing responses are better when an internal matrix, whether HAPSET or hydroxyapatite, is used in the repair of furcation perforations.


Assuntos
Processo Alveolar/lesões , Materiais Biocompatíveis/uso terapêutico , Substitutos Ósseos/uso terapêutico , Sulfato de Cálcio/uso terapêutico , Cavidade Pulpar/lesões , Durapatita/uso terapêutico , Raiz Dentária/lesões , Processo Alveolar/patologia , Processo Alveolar/cirurgia , Animais , Dente Pré-Molar , Tecido Conjuntivo/patologia , Amálgama Dentário , Cavidade Pulpar/patologia , Cavidade Pulpar/cirurgia , Modelos Animais de Doenças , Epitélio/patologia , Feminino , Células Gigantes/patologia , Dente Molar , Osteoblastos/patologia , Osteoclastos/patologia , Osteogênese , Papio , Bolsa Periodontal/patologia , Distribuição Aleatória , Materiais Restauradores do Canal Radicular , Obturação do Canal Radicular , Fatores de Tempo , Raiz Dentária/patologia , Raiz Dentária/cirurgia , Cicatrização
18.
Braz Dent J ; 13(2): 103-8, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12238799

RESUMO

This study evaluated the clinical and histological manifestations produced by the submucuous implant of abrasive dental materials in the rat tongue. A total of 128 rats were divided into 4 groups of 32 rats each, according to the material selected for the implant: Herjos-F prophylactic paste both in its normal composition as well as lacking its abrasive components, SS White pumice stone and the abrasive powder of the 3M finishing and polishing sandpaper. The specimens were submitted to clinical and histological analyses at 30, 60, 90 and 120 days. After 90 days, the formation of nodular lesions in animals implanted with materials containing abrasive substances was observed. Histologically, these materials produced marked chronic granulomatous reactions. Herjos-F prophylactic paste produced the greatest reaction. However, without the abrasive components, this paste caused the mildest tissue reactions, with no inflammatory response, that was seen in a progressively greater number of cases after 90 days.


Assuntos
Materiais Biocompatíveis/química , Materiais Dentários/química , Língua/patologia , Óxido de Alumínio/química , Animais , Carbonato de Cálcio/química , Distribuição de Qui-Quadrado , Eosinófilos/patologia , Corpos Estranhos/patologia , Células Gigantes/patologia , Granuloma de Corpo Estranho/patologia , Hiperplasia , Linfócitos/patologia , Macrófagos/patologia , Neutrófilos/patologia , Plasmócitos/patologia , Distribuição Aleatória , Ratos , Ratos Wistar , Silicatos/química , Dióxido de Silício/química , Estatísticas não Paramétricas , Fatores de Tempo , Língua/cirurgia , Cremes Dentais/química
19.
Acta pediatr. esp ; 60(7): 348-349, jul. 2002. ilus
Artigo em Es | IBECS | ID: ibc-12898

RESUMO

El granuloma anular es un proceso cutáneo inflamatorio de causa desconocida que aparece con mayor frecuencia en la infancia. El diagnóstico se basa, fundamentalmente, en la anatomía patológica, que demuestra la existencia de granulomas necrobióticos en la dermis. Los tratamientos actuales son poco efectivos; sin embargo, suele aparecer una evolución hacia la curación espontánea en el 50 por ciento de los casos, por lo que, a veces, no efectuar tratamiento es una opción aceptable (AU)


Assuntos
Feminino , Criança , Humanos , Granuloma Anular/diagnóstico , Granuloma Anular/tratamento farmacológico , Corticosteroides/administração & dosagem , Corticosteroides/uso terapêutico , Necrobiose Lipoídica/complicações , Necrobiose Lipoídica/diagnóstico , Necrobiose Lipoídica/tratamento farmacológico , Terapia Ultravioleta/métodos , Células Gigantes/patologia , Terapia PUVA/métodos , Terapia PUVA , Terapia PUVA/tendências
20.
Braz. dent. j ; 13(2): 103-108, 2002.
Artigo em Inglês | LILACS | ID: lil-332152

RESUMO

This study evaluated the clinical and histological manifestations produced by the submucuous implant of abrasive dental materials in the rat tongue. A total of 128 rats were divided into 4 groups of 32 rats each, according to the material selected for the implant: Herjos-F prophylactic paste both in its normal composition as well as lacking its abrasive components, SS White pumice stone and the abrasive powder of the 3M finishing and polishing sandpaper. The specimens were submitted to clinical and histological analyses at 30, 60, 90 and 120 days. After 90 days, the formation of nodular lesions in animals implanted with materials containing abrasive substances was observed. Histologically, these materials produced marked chronic granulomatous reactions. Herjos-F prophylactic paste produced the greatest reaction. However, without the abrasive components, this paste caused the mildest tissue reactions, with no inflammatory response, that was seen in a progressively greater number of cases after 90 days.


Assuntos
Animais , Ratos , Língua/patologia , Materiais Biocompatíveis/química , Materiais Dentários/química , Carbonato de Cálcio , Células Gigantes/patologia , Distribuição de Qui-Quadrado , Dióxido de Silício/química , Eosinófilos/patologia , Corpos Estranhos , Granuloma de Corpo Estranho , Hiperplasia , Língua/cirurgia , Linfócitos , Macrófagos/patologia , Neutrófilos/patologia , Óxido de Alumínio/química , Plasmócitos , Distribuição Aleatória , Ratos Wistar , Silicatos , Estatísticas não Paramétricas , Fatores de Tempo , Cremes Dentais
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA